AU2001278010A1 - Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue - Google Patents
Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissueInfo
- Publication number
- AU2001278010A1 AU2001278010A1 AU2001278010A AU7801001A AU2001278010A1 AU 2001278010 A1 AU2001278010 A1 AU 2001278010A1 AU 2001278010 A AU2001278010 A AU 2001278010A AU 7801001 A AU7801001 A AU 7801001A AU 2001278010 A1 AU2001278010 A1 AU 2001278010A1
- Authority
- AU
- Australia
- Prior art keywords
- ischemic tissue
- bone marrow
- skeletal muscle
- cell transplantation
- derived cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
- C12N5/0692—Stem cells; Progenitor cells; Precursor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22083400P | 2000-07-26 | 2000-07-26 | |
US60/220,834 | 2000-07-26 | ||
PCT/US2001/023438 WO2002008389A2 (en) | 2000-07-26 | 2001-07-26 | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001278010A1 true AU2001278010A1 (en) | 2002-02-05 |
Family
ID=22825164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001278010A Abandoned AU2001278010A1 (en) | 2000-07-26 | 2001-07-26 | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
Country Status (6)
Country | Link |
---|---|
US (2) | US6878371B2 (en) |
EP (1) | EP1303588B1 (en) |
JP (1) | JP2004516242A (en) |
AU (1) | AU2001278010A1 (en) |
CA (1) | CA2429502A1 (en) |
WO (1) | WO2002008389A2 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8075880B2 (en) * | 1999-01-11 | 2011-12-13 | Steward St. Elizabeth's Medical Center Of Boston, Inc. | Compositions and methods for regulating angiogenesis |
US7125714B2 (en) | 1997-02-05 | 2006-10-24 | Licentia Ltd. | Progenitor cell materials and methods |
WO2001020999A1 (en) * | 1999-09-23 | 2001-03-29 | Trimedyne, Inc. | Materials and methods for inducing angiogenesis and the repair of mammalian tissue |
EP1303588B1 (en) * | 2000-07-26 | 2012-10-24 | Boston Scientific Limited | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
FR2830936B1 (en) * | 2001-10-16 | 2004-08-27 | Agronomique Inst Nat Rech | METHOD FOR MEASURING THE STATE OF TENSION OF A MATERIAL AND APPLICATIONS OF THIS METHOD |
WO2007116408A2 (en) * | 2006-04-11 | 2007-10-18 | Nanodiagnostics Israel Ltd. | Pluripotent stem cells characterized by expression of germline specific genes |
CA2493768A1 (en) * | 2002-07-23 | 2004-01-29 | Nanodiagnostics, Inc. | Embryonic stem cell markers and uses thereof |
WO2004044142A2 (en) * | 2002-11-05 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Mesenchymal stem cells and methods of use thereof |
WO2004052177A2 (en) * | 2002-12-05 | 2004-06-24 | Case Western Reserve University | Cell-based therapies for ischemia |
US7470538B2 (en) * | 2002-12-05 | 2008-12-30 | Case Western Reserve University | Cell-based therapies for ischemia |
JPWO2004074494A1 (en) * | 2003-02-19 | 2006-06-01 | 株式会社ディナベック研究所 | Treatment method for ischemic disease |
EP1469064A1 (en) * | 2003-04-15 | 2004-10-20 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Expression of proteins in endothelial cells derived from precursor cells from cord blood |
US7195598B2 (en) * | 2003-05-23 | 2007-03-27 | Siemens Aktiengesellschaft | Method for determining the effectiveness of a medical therapy by analysis of collateral vessels |
EP1713903A2 (en) | 2004-02-09 | 2006-10-25 | Indiana University Research and Technology Corporation | Isolation, expansion and use of clonogenic endothelial progenitor cells |
WO2005093044A1 (en) * | 2004-03-22 | 2005-10-06 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
EP1745125A1 (en) | 2004-05-14 | 2007-01-24 | Becton, Dickinson and Company | Cell culture environments for the serum-free expansion of mesenchymal stem cells |
US7364657B2 (en) * | 2005-03-31 | 2008-04-29 | Abbott Cardiovascular Systems Inc. | Integrated system for on-site cell acquisition, processing, and delivery |
CN1928111B (en) * | 2005-09-09 | 2011-04-20 | 中国科学院上海生命科学研究院 | Correlation analysis of circulation endothelium progenitor cell and coronary artery pathological changes |
US7736346B2 (en) * | 2005-10-18 | 2010-06-15 | Biocardia, Inc. | Bio-interventional therapeutic treatments for cardiovascular diseases |
PL1951864T3 (en) * | 2005-11-07 | 2014-10-31 | Pecora & Co Llc | Compositions and methods of vascular injury repair |
WO2007119240A2 (en) * | 2006-04-17 | 2007-10-25 | Hepacore Ltd. | Methods for bone regeneration using endothelial progenitor cell preparations |
US9255249B2 (en) * | 2006-05-17 | 2016-02-09 | Cognate Bioservices, Inc. | Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates |
ES2441560T3 (en) * | 2006-11-03 | 2014-02-05 | Aastrom Biosciences, Inc. | Mixed cell populations for tissue repair and separation technique for cell processing |
WO2008085229A2 (en) * | 2006-11-15 | 2008-07-17 | Arteriocyte Inc. | Cell-based therapies for treating liver disease |
US20100143476A1 (en) * | 2007-02-14 | 2010-06-10 | March Keith L | Composition for stimulating formation of vascular structures |
US8273253B2 (en) | 2007-03-02 | 2012-09-25 | Smith & Nephew Plc | Apparatus and method for filter cleaning by ultrasound, backwashing and filter movement during the filtration of biological samples |
US8496926B2 (en) | 2007-04-16 | 2013-07-30 | Biocardia, Inc. | Treatment for chronic myocardial infarction |
CN101668848B (en) * | 2007-04-26 | 2014-10-22 | 雷蒙特亚特特拉维夫大学有限公司 | Pluripotent autologous stem cells from oral mucosa and methods of use |
US20080300642A1 (en) * | 2007-05-30 | 2008-12-04 | Japan As Represented By President Of National Cardiovascular Center | Regeneration treatment apparatus, operating method thereof, and regeneration treatment method |
CN102105226B (en) | 2008-07-25 | 2015-01-21 | 史密夫及内修公开有限公司 | Controller for an acoustic standing wave generation device in order to prevent clogging of a filter |
US20100035297A1 (en) * | 2008-08-08 | 2010-02-11 | Indiana University Research And Technology Corporation | Methods and compositions for vasculogenic potential determination |
WO2011121036A2 (en) | 2010-03-30 | 2011-10-06 | Vib Vzw | Induction of arteriogenesis using specific factors or by cell therapy with polarized myeloid cells |
CN101940592B (en) * | 2010-08-27 | 2014-06-25 | 上海士腾生物技术有限公司 | Preparation for treating ischemic cerebrovascular disease and preparation method thereof |
WO2012048275A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
WO2014110180A1 (en) * | 2013-01-12 | 2014-07-17 | Cesca Therapeutics, Inc. | Rapid infusion of autologous bone marrow derived stem cells |
US10293031B2 (en) | 2013-10-16 | 2019-05-21 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Compositions and methods for promoting the mineralization of biological tissue |
US10633625B2 (en) | 2013-11-16 | 2020-04-28 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
EP3122866B1 (en) | 2014-03-25 | 2019-11-20 | Terumo BCT, Inc. | Passive replacement of media |
JP6830059B2 (en) | 2014-09-26 | 2021-02-17 | テルモ ビーシーティー、インコーポレーテッド | Scheduled cell feeding |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
EP3464565A4 (en) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | Cell expansion |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
WO2018184028A2 (en) | 2017-03-31 | 2018-10-04 | Terumo Bct, Inc. | Cell expansion |
KR102503086B1 (en) * | 2017-09-08 | 2023-02-23 | 가부시키가이샤 오츠카 세이야쿠 고죠 | Young pig-derived stem cells and method for producing the same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5980887A (en) * | 1996-11-08 | 1999-11-09 | St. Elizabeth's Medical Center Of Boston | Methods for enhancing angiogenesis with endothelial progenitor cells |
US20030125615A1 (en) * | 1998-02-05 | 2003-07-03 | Yitzhack Schwartz | Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
WO2000006701A1 (en) * | 1998-07-31 | 2000-02-10 | Genzyme Corporation | Improvement of cardiac function by mesenchymal stem cell transplantation |
DE60035035T2 (en) * | 1999-03-30 | 2008-01-31 | Kornowski, Ran | INJECTION OF AUTOLOGOUS BONE MARROW IN THE HEART MUSCLES |
US7097832B1 (en) * | 1999-03-30 | 2006-08-29 | Myocardial Therapeutics, Inc. | Intramyocardial injection of autologous bone marrow |
WO2001020999A1 (en) | 1999-09-23 | 2001-03-29 | Trimedyne, Inc. | Materials and methods for inducing angiogenesis and the repair of mammalian tissue |
WO2001022978A2 (en) * | 1999-09-30 | 2001-04-05 | Mcgill University | Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
JP2002020298A (en) * | 2000-07-10 | 2002-01-23 | Junkanki Kenkyusho:Kk | Neovascularization promoter |
EP1303588B1 (en) * | 2000-07-26 | 2012-10-24 | Boston Scientific Limited | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
US7138144B2 (en) * | 2001-09-07 | 2006-11-21 | Nadir Askenasy | Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation |
-
2001
- 2001-07-26 EP EP01955962A patent/EP1303588B1/en not_active Revoked
- 2001-07-26 US US09/915,853 patent/US6878371B2/en not_active Expired - Lifetime
- 2001-07-26 WO PCT/US2001/023438 patent/WO2002008389A2/en active Application Filing
- 2001-07-26 AU AU2001278010A patent/AU2001278010A1/en not_active Abandoned
- 2001-07-26 CA CA002429502A patent/CA2429502A1/en not_active Abandoned
- 2001-07-26 JP JP2002513874A patent/JP2004516242A/en active Pending
-
2005
- 2005-02-28 US US11/069,166 patent/US7799349B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1303588A2 (en) | 2003-04-23 |
US6878371B2 (en) | 2005-04-12 |
EP1303588B1 (en) | 2012-10-24 |
JP2004516242A (en) | 2004-06-03 |
WO2002008389A3 (en) | 2002-10-10 |
WO2002008389A9 (en) | 2003-06-12 |
US7799349B2 (en) | 2010-09-21 |
WO2002008389A2 (en) | 2002-01-31 |
US20020037278A1 (en) | 2002-03-28 |
CA2429502A1 (en) | 2002-01-31 |
US20050147597A1 (en) | 2005-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001278010A1 (en) | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue | |
AU2001275339A1 (en) | Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury | |
IL159895A0 (en) | Methods of generating human cardiac cells and tissues and uses thereof | |
EP1437406A4 (en) | Pluripotent stem cells originating in skeletal muscle intestinal tissue | |
IL183853A0 (en) | New oxabispidine compounds useful in the treatment of cardiac arrhythmias | |
IL154769A0 (en) | Cardiac arrhythmia treatment methods | |
IL139708A0 (en) | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering | |
PT1066838E (en) | Bone tissue regenerating composition | |
AU6372900A (en) | Linkage of agents to tissue | |
HK1047250A1 (en) | Tissue augmentation material and methods | |
AU2001238363A1 (en) | Compositions for preventing cellulite in mammalian skin | |
EP1185555A4 (en) | Compositions isolated from skin cells and methods for their use | |
HUP0302288A3 (en) | New oxabispidine compound useful in the treatment of cardiac arrhythmias | |
EP1200133A4 (en) | Manipulation of tissue or organ type using the notch pathway | |
IL145260A0 (en) | Cosmetic stick composition | |
AU5134600A (en) | Full-length molecules expressed in human tissues | |
PL354032A1 (en) | New bispidine compounds useful in the treatment of cardiac arrhythmias | |
AU2002210961A1 (en) | Novel gene overexpressed in heart and skeletal muscle and use tehreof | |
PL353794A1 (en) | New bispidine compounds useful in the treatment of cardiac arrhythmias | |
HK1045508A1 (en) | New bispidine compounds useful in the treatment of cardiac arrhythmias | |
WO2001007605A8 (en) | Immunosuppression by cell surface expression of recombinant cd154 | |
TW389038U (en) | Structure of multi-functional walking stick | |
GB0001990D0 (en) | Improvements in or relating to expandable bone nails | |
IL146751A0 (en) | New bispidine compounds useful in the treatment of cardiac arrhythmias | |
GB9905469D0 (en) | Improvements in or relating to surgical devices |